NPS Pharmaceuticals, Inc.
550 Hills Drive
3rd Floor
Bedminster,
NJ 07921
United States - Map
Phone: 908-450-5300
Fax: 908-450-5351
Web Site: http://www.npsp.com
| NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of specialty therapeutics for gastrointestinal and endocrine disorders. It is advancing two late-stage programs to restore or replace biological function, including GATTEX (teduglutide), which is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome; and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) that is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism. The company also completed a Phase 3 osteoporosis study for PREOS (parathyroid hormone 1-84 [rDNA origin] injection). In addition, it is developing NPSP156, which is in preclinical stage for the treatment of central nervous system disorders. NPS Pharmaceuticals complements its internal programs with strategic partnerships with Amgen, GlaxoSmithKline, Kirin, Janssen, and Nycomed. The company was founded in 1986 and is headquartered in Bedminster, New Jersey. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Francois Nader MD, MBA, 51
Chief Exec. Officer, Pres |
$
648.00K | N/A | Mr. Luke M. Beshar , 49
Chief Financial Officer, Principal Accounting Officer and Sr. VP |
$
45.00K | N/A | Mr. Andrew Rackear , 53
Sr. VP of Legal Affairs, Gen. Counsel and Sec. |
$
170.00K | N/A | Dr. Alan G. Harris MD, PhD, FACP, 57
Chief Medical Officer and Sr. VP |
N/A
| N/A | Dr. Bo Joelsson M.D. Ph.D.,
Head of Clinical Research |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-07
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.58% Nasdaq 
1.21%
Profile
